View : 268 Download: 0
Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice
- Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice
- Park J.-S.; Shin J.A.; Jung J.-S.; Hyun J.-W.; Van Le T.K.; Kim D.-H.; Park E.-M.; Kim H.-S.
- Ewha Authors
- 김희선; 박은미
- SCOPUS Author ID
- 김희선; 박은미
- Issue Date
- Journal Title
- Journal of Pharmacology and Experimental Therapeutics
- Journal of Pharmacology and Experimental Therapeutics vol. 341, no. 1, pp. 59 - 67
- SCIE; SCOPUS
- Document Type
- Microglial activation plays a pivotal role in the pathogenesis of various neurologic disorders, such as cerebral ischemia, Alzheimer's disease, and Parkinson's disease. Thus, controlling microglial activation is a promising therapeutic strategy for such brain diseases. In the present study, we found that a ginseng saponin metabolite, compound K [20-O-D-glucopyranosyl- 20(S)-protopanaxadiol], inhibited the expressions of inducible nitric-oxide synthase, proinflammatory cytokines, monocyte chemotactic protein-1, matrix metalloproteinase-3, and matrix metalloproteinase-9 in lipopolysaccharide (LPS)- stimulated BV2 microglial cells and primary cultured microglia. Subsequent mechanistic studies revealed that compound K suppressed microglial activation via inhibiting reactive oxygen species, mitogen-activated protein kinases, and nuclear factor-κB/ activator protein-1 activities with enhancement of heme oxygenase-1/antioxidant response element signaling. To address the anti-inflammatory effects of compound K in vivo, we used two brain disease models of mice: sepsis (systemic inflammation) and cerebral ischemia. Compound K reduced the number of Iba1-positive activated microglia and inhibited the expressions of tumor necrosis factor-α and interleukin-1β in the LPS-induced sepsis brain. Furthermore, compound K reduced the infarct volume of ischemic brain induced by middle cerebral artery occlusion and suppressed microglial activation in the ischemic cortex. The results collectively suggest that compound K is a promising agent for prevention and/or treatment of cerebral ischemia and other neuroinflammatory disorders. Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics.
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- RIS (EndNote)
- XLS (Excel)
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.